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Abstract
The failure of an osseous fracture to heal (development of a non-union) is a common and debilitating clinical problem. Mice
lacking the tumor suppressor Pten in osteoblasts have dramatic and progressive increases in bone volume and density
throughout life. Since fracture healing is a recapitulation of bone development, we investigated the process of fracture
healing in mice lacking Pten in osteoblasts (Ocn-cretg/+;Ptenflox/flox). Mid-diaphyseal femoral fractures induced in wild-type
and Ocn-cretg/+;Ptenflox/flox mice were studied via micro-computed tomography (mCT) scans, biomechanical testing,
histological and histomorphometric analysis, and protein expression analysis. Ocn-cretg/+;Ptenflox/flox mice had significantly
stiffer and stronger intact bones relative to controls in all cohorts. They also had significantly stiffer healing bones at day
28 post-fracture (PF) and significantly stronger healing bones at days 14, 21, and 28 PF. At day 7 PF, the proximal and distal
ends of the Pten mutant calluses were more ossified. By day 28 PF, Pten mutants had larger and more mineralized calluses.
Pten mutants had improved intramembranous bone formation during healing originating from the periosteum. They also
had improved endochondral bone formation later in the healing process, after mature osteoblasts are present in the callus.
Our results indicate that the inhibition of Pten can improve fracture healing and that the local or short-term use of
commercially available Pten-inhibiting agents may have clinical application for enhancing fracture healing.
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Introduction
Fracture healing is a complex process involving several
overlapping stages: inflammation, formation of soft and hard
callus, and bone remodeling [1]. As a recapitulation of
embryonic skeletal development [2], fracture repair follows a
one-way path of similarly regulated chondrogenic and osteo-
blastic phases of bone formation leading toward bone healing
and remodeling. Most fractures heal by a combination of
endochondral and intramembranous ossification [3]. In endo-
chondral ossification, bone formation occurs from a cartilagi-
nous template [4]. In intramembranous ossification, bone forms
directly from the cortical bone and periosteum to bridge the
fracture gap [4], but it is rare for a fracture to heal exclusively
by this mechanism [3]. It is estimated that 10–20% of fractures
do not heal in a timely manner [5,6]. The increased costs for
treatment of impaired healing (non-union) and the increased
morbidity for the individual patients [7] makes enhancing the
process of fracture healing an important priority.
Skeletal development is regulated by morphogens (e.g., bone
morphogenic proteins) [8] and growth factors (e.g., insulin-like
growth factor 1) [9]. These growth factors regulate osteoblast
differentiation, maturation, and survival through the anti-apoptot-
ic pathways [10]. The lipid kinase phosphatidylinositol 3-kinase
(PI3K) is involved in these pathways [11]. PI3K phosphorylates
PI(4)P or PI(4,5)P2 to produce the second messengers PI(3,4)P2
and PI(3,4,5)P3 (known as PIP3) [11]. A major downstream target
of PIP3 is Akt. PIP3 recruits Akt and PI-dependent kinase 1
(PDK1), and then PDK1 phosphorylates Akt, which causes it to be
activated [11]. Activated Akt promotes cell growth, proliferation,
survival, and metabolism [12], and regulates pathways related to
GSK3 [11], BAD/Bcl-XL [11], p53 [13], and mTOR [14].
The PTEN gene (phosphatase and tensin homologue deleted on
human chromosome 10) encodes a PIP phosphatase that
dephosphorylates PIP3 and negatively regulates activation induced
by PI3K. PTEN is deleted or inactivated in various types of tumors
[15]. PTEN blocks the activation of Akt, affecting cell cycling,
translation, and apoptosis [15]. When PTEN function is blocked,
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PIP3 accumulates and Akt is continually activated and results in
increased in cell proliferation, survival, and migration [16]. Mice
carrying a Cre-mediated osteoblast-specific deletion of the Pten
gene (Ocn-cretg/+;Ptenflox/flox) had normal body size but showed
dramatic and progressive increases in bone volume and density
throughout life [17]. Osteoblasts from such mutant mice were less
susceptible to apoptosis and had accelerated differentiation
capacity [17]. These findings provide in vivo evidence that
signaling via the PI3K/Pten pathway promotes osteoblast survival
and function. Based on these findings, we hypothesize that
inhibition of Pten in osteoblasts will lead to improved and more
rapid fracture healing.
Methods
This study was approved by the Institutional Animal Care and
Use Committee at the Van Andel Research Institute. Mice lacking
Pten in osteoblasts (Ocn-cretg/+;Ptenflox/flox) and wild-type controls
(Ocn-cre+/+;Ptenflox/flox) mice were generated [17]. To examine
fracture healing and biomechanical characteristics, surgery was
performed on 126 mice that were 11–12 weeks old following an
established procedure [18]. Each animal was anesthetized using a
subcutaneous weight-matched dose of tribromoethanol (average
350 mL dose of 0.079 mg/mL solution; Avertin; Winthrop
Laboratories, New York). The fur on the right leg was removed
and the patella was moved laterally to expose the distal femur. A
25-gauge needle was inserted retrograde in the femoral canal at
the intercondylar notch and was advanced until it reached the
cortex of the proximal femur. The needle was cut at the distal end
with minimal distal intraarticular protrusion and was positioned
like an intramedullary nail is in human long bone fractures [19].
This needle will not deter osteoblasts from forming bone in the
callus because osteoblast progenitors enter the callus with invading
blood vessels [20]. The patella was relocated and the knee
arthrotomy was closed with a 6.0 silk suture to maintain patella
positioning. The skin was closed with a surgical staple. Standard-
ized radiographic imaging (PixArray 100, Bioptix Inc., Tucson,
Arizona) was performed using standardized settings (approximate-
ly 31 kV for 9 s) to confirm needle positioning. A right mid-
diaphyseal femoral fracture was created using a blunt impact force
in a validated three-point bending technique [18]. Standardized
radiographic imaging confirmed fracture location and type.
Postoperative pain medication was managed with subcutaneous
doses of tramadol [21] (20 mg/kg; Sigma-Aldrich, St. Louis, MO)
administered at the time of surgery and at 12, 24, and 36 h after
fracture.
Mice were divided into three groups: biomechanical and mCT
evaluation (n = 66), histological evaluation (n = 30), and protein
expression (n = 30). For the biomechanical and mCT evaluation, 45
fractured femurs and 66 intact, contralateral femurs and were
used; 21 fractured femurs (10 wild-type and 11 Pten mutant
Figure 1. Fracture femoral (A) stiffness and (B) maximum
strength. Pten mutants had significantly higher stiffness at 28 d PF
and maximum strength at 14, 21, and 28 d PF in fractured femurs. The
stiffness and strength increased for both the wild-type and mutant
groups during the healing process. (*p,0.05, **p,0.01, and
***p,0.001 WT to Mut at the time point.).
doi:10.1371/journal.pone.0063857.g001
Figure 2. Representative longitudinal mCT sections of the
fracture. The Pten mutants had more bone formation at the proximal
and distal ends of the fracture callus at each time point.
doi:10.1371/journal.pone.0063857.g002
Pten Knockouts Have Improved Fracture Healing
PLOS ONE | www.plosone.org 2 May 2013 | Volume 8 | Issue 5 | e63857
animals) were excluded because the fracture was oblique,
comminuted or incomplete, as determined by follow-up radio-
graphs. Thirty mice were used for histological evaluation, and
representative samples were chosen. Mice were sacrificed at 7, 14,
21, and 28 d PF.
Biomechanical and mCT Evaluation
Both the fractured and intact femurs were excised and cleaned
of the surrounding soft tissue. The intramedullary needles in the
fractured femurs were removed and samples were stored at –20uC
in saline-saturated gauze. The fractured and contralateral control
femurs were scanned in saline by m-computed tomography (mCT)
using a Skyscan 1172 high-resolution micro-CT (Skyscan, Kon-
tich, Belgium) with a voxel size of 13.3 mm. The two Skyscan
calibration phantoms were included in each scan. Images were
reconstructed using the Skyscan software.
In a repeated series of steps similar to methods in previous
studies [22,23], each phantom and femur was segmented into
separate masks and made into three-dimensional volumes (Mimics
x64 14.11, Materialise, Ann Arbor, MI; Figure S1a). Global
thresholding based on Hounsfield unit (HU) was used to
differentiate the cortical bone from the surrounding saline. The
‘‘3D LiveWire’’ tool was used to supplement the thresholding to
differentiate the boundary of the callus from the saline. The
‘‘Region Growing’’ tool was used to separate the fractured and
intact limbs from the thresholded mask, and a Boolean addition
was made of the thresholded and 3D LiveWire regions for the
fractured limb. The ‘‘Calculate Polylines’’ tool was used to draw
polylines around the Boolean addition mask for the fractured limb
and the region growing mask for the intact limb, and the ‘‘Cavity
Fill From Polylines’’ tool was used so that no voxels were excluded
from the volume of each segmented bone. The masks were
cropped to include a uniform length of the bone from the
intersection of the femoral neck and the greater trochanter to the
intersection of the patellar groove and the diaphysis.
The volume and average HU of the masks was measured using
Mimics. The linear relationship between the bone mineral content
Figure 3. Representative mCT cross sections of bone formation from the periosteum. Sections were taken an average of 2.7 mm away
from the fracture. A black line was drawn around the existing bone to indicate the transition between it and newly formed bone. The Pten mutants
had more ossification, especially around the existing bone, at each time point.
doi:10.1371/journal.pone.0063857.g003
Figure 4. BV/TV mCT callus analysis: (A) BV/TV in proximal and
distal callus ends, (B) BV/TV in center of callus. Pten mutants had
higher BV/TV at each time point in ends and center. (*p,0.05 WT to
Mut at the time point.).
doi:10.1371/journal.pone.0063857.g004
Pten Knockouts Have Improved Fracture Healing
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and HU [24,25] of each scan was calculated from the known
density of the two calibration phantoms (0.25 g/cm3 and 0.75 g/
cm3) and their segmented HU values. This relationship was used
to calculate the mineral density of the segmented fractured femur
mask and intact femur. The mineral content of the fractured
femur and the intact femur was found by multiplying each mask
density by mask volume. The callus volume was calculated as the
volume of the fractured femur (bone and callus) minus the volume
of the intact femur (only bone), as shown in Figure S1b. The callus
mineral content was calculated using the same method. The callus
density was calculated as the callus mineral content divided by the
callus volume.
For BV/TV analysis, five transverse slices were acquired: three
in the central callus and two at the ends. One slice was taken at the
center of the largest portion of callus and two more 0.5 mm
proximal and distal to the determined center. The other two slices
were taken at the proximal and distal ends of the callus. Using
both sagittal and coronal cross-sections, the positions of the
proximal and distal ends of the callus were determined by locating
the point at which the edge of the callus intersected the intact
portion of the fractured limb. A slice 1.0 mm distal to the proximal
end of the callus and a slice 1.0 mm proximal to the distal end of
the callus were used to characterize the amount of bone tissue at
the proximal and distal ends of the callus, respectively.
The Digital Imaging and Communications in Medicine
(DICOM) standard data files of the transverse slices were analyzed
for mature callus area at a threshold of 600 mg/cm3 [26] using the
‘‘slice geometry’’ macro of BoneJ [27], a bone image analysis
plugin for ImageJ (ImageJ 1.46, National Institutes of Health,
Bethesda, MD). The mature (bone volume; BV) and total callus
volume (TV) of each slice was measured and averaged for each
region; BV/TV was calculated for each region. The central slices
for day 7 were excluded because there was little to no
endochondral ossification in groups at that time point.
For biomechanical assessment of the bones, all femurs were
removed from the freezer, rehydrated in saline, and allowed to
equilibrate to room temperature for at least 30 minutes. Four-
point bending mechanical testing was performed on the right
femur at a rate of 0.005 mm/s with a TestResources 570 L axial-
torsional testing system (TestResources, Shakopee, MN). The
distances between the lower and upper supports were 8.0 mm and
4.0 mm (Figure S1c). The supports had a radius of 0.5 mm at the
point of contact with the bone. The load was applied in the
anterior to posterior direction so that the anterior side was in
compression and the posterior side was in tension. Force and
displacement were directly measured by the TestResources
system. Stiffness and maximum strength (maximum load) were
calculated. Biomechanical properties were normalized by dividing
the fractured property by the intact property.
Histological Evaluation
For histological analysis, femurs were excised, fixed in 10%
neutral buffered formalin for at least 24 h, and decalcified in
Immunocal decalcifying agent (Decal Chemical Corporation,
Tallman, NY) at room temperature for 24 h. The samples were
embedded in paraffin, sectioned (5 mm), and stained with
hematoxylin and eosin (H&E). Immunohistochemistry was
performed for proteins in the PI3K/Pten pathway (p-Akt:
#3787, 1:50 dilution in 0.1% BSA, Cell Signaling Technology,
Danvers, MA; p-S6, #4857, 1:75 dilution; Pten, #9559, 1:200
dilution; see Document S1). Tartrate-resistant acid phosphatase
(TRAP) staining for osteoclasts was performed using a leukocyte
acid phosphatase kit (#387A, Sigma-Aldrich, St. Louis, MO) and
counterstained with hematoxylin.
Histomorphometry Analysis
Measurements were performed on Goldner’s Trichrome stained
sections (three samples per genotype per day) using Bioquant
Osteo 2012 imaging software (Bioquant Imaging Corporation,
Nashville, TN). Endosteal bone surfaces were measured within the
callus on the outside of the cortical bone on both the medial and
lateral side or the anterior and posterior side, depending on the
plane of section. The measurement area extended 0.6 mm on
either side of the fracture site if possible. All measurement data was
Figure 5. mCT callus analysis: (A) callus mineral content, (B)
callus volume, (C) callus mineral density. Pten mutants had more
callus mineral content, volume and density at each time point.
(*p,0.05 WT to Mut at the time point.).
doi:10.1371/journal.pone.0063857.g005
Figure 6. p-Akt and Pten protein expression during healing.
Pten mutants had increased p-Akt expression at days 21 and 28 PF.
doi:10.1371/journal.pone.0063857.g006
Pten Knockouts Have Improved Fracture Healing
PLOS ONE | www.plosone.org 4 May 2013 | Volume 8 | Issue 5 | e63857
pooled. Endosteal bone surfaces were traced within the measure-
ment area. The surfaces were characterized as quiescent,
osteoblast surface, and erosion surface with or without osteoclast.
Osteoclast surface is the sum of erosion surface with osteoclast and
osteoclast surface with no erosion. The osteoblast and osteoclast
cell numbers were then counted. Periosteal surfaces were excluded
from the measurement area.
Analysis of Protein Expression
For analysis of protein expression, the fracture callus and
corresponding segment of the contralateral femur were harvested
and the bone marrow was flushed out of the medullary canal with
saline. The femurs were homogenized in a Fast Prep-24 tissue and
cell homogenizer (MP Biomedicals, Solon, OH) with Lysing
Matrix M (Product # 116923050, MP Biomedicals) and one
added J’’ ceramic sphere (Product # 116540034, MP Biomed-
icals) per sample. The samples were in a p300 lysis buffer [28]
Figure 7. H&E of fracture calluses at day 14 PF. (A) 46 magnification of wild-type callus; (B) 106 magnification of the box from (A); (C) 46
magnification of Pten mutant callus; and (D) 106magnification of box from (C). Woven bone was spread throughout the callus and was surrounded
hypertrophic chondrocytes in both cases.
doi:10.1371/journal.pone.0063857.g007
Figure 8. TRAP stain of fracture calluses at day 14 PF. (A) 106magnification of wild-type callus; (B) 206magnification of box from (A); (C) 106
magnification of Pten mutant callus; (D) 206magnification of box from (C). TRAP staining was more intense in the mutant group.
doi:10.1371/journal.pone.0063857.g008
Pten Knockouts Have Improved Fracture Healing
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supplemented with 0.5 mM sodium orthovanadate. The Fast
Prep-24 was run at 6.0 m/s for 40 seconds for four cycles with five
minutes in between cycles. The protein lysate was centrifuged at
16,000 g at 4uC for 10 minutes and stored at –80uC. Forty
micrograms of lysate were separated on SDS/10% polyacrylamide
gels and transferred to nitrocellulose membranes. After probing
with primary antibodies (p-Akt, Pten and b-actin at 1:1000,
Product # 4058, 9559 and 4970, respectively, Cell Signaling,
Danvers, MA), the membranes were incubated with horseradish
peroxidase-linked secondary donkey, anti-rabbit antibodies (Prod-
uct # 2313, Santa Cruz Biotechnology, Inc., Santa Cruz, CA),
and bound antibodies were visualized using Amersham Hyperfilm
(Product # 28-9068-35, GE Healthcare, Piscataway, NJ).
Three western blots were scanned in grayscale using a Scanjet
G4050 scanner (Hewlett-Packard, Palo Alto, CA) at 1200 dpi. The
scans were imported into ImageJ (version 1.46) and the color was
inverted so the bands were light on a dark background. A uniform
box was drawn around each band and the mean intensity was
measured. The intensity of the blot background was determined
from the average of three measurements with the same uniform
box size. The background was subtracted from the p-Akt, Pten
and b-actin bands. The resulting intensity of the p-Akt and Pten
bands each were normalized to the intensity of the b-actin band.
One common sample was run on each western blot as a standard
control. For each blot, the intensity ratio of Pten to b-actin was
found for this standard, and all other bands on that western blot
were normalized to the intensity ratio of the standard so that band
intensity ratios could be compared across separate western blots.
Statistical Analyses
The effects of genotype and time after fracture were assessed
statistically. Since some measures did not satisfy the student’s t-test
assumptions of normal distribution and equal variance, non-
parametric Mann-Whitney U tests were performed on all
measures (PASW Statistics 18, SPSS, Inc., Chicago, IL). All
analyses were carried out with p,0.05 considered significant.
Average and standard deviation are reported.
Results
We assessed the stiffness and maximum strength in Ocn-cretg/
+;Ptenflox/flox (Pten mutant) and wild-type femurs intact and during
the process of fracture repair (Figure 1). Intact contralateral bones
from the mutant mice had significantly greater stiffness and
maximum load at failure (p,0.01 or p,0.001) than those of the
wild-type animals at each time point (Figure 1a, d). As expected,
the stiffness and strength increased throughout healing in both
wild-type and mutant animals (Figure 1b, e). Relative to the wild-
type, Pten mutants had significantly higher stiffness at 28 days PF
and significantly higher maximum strength at 14, 21 and 28 days
PF in the fractured femurs (Figure 1b, e). At day 7 PF for both the
wild-type and mutant groups, the fractured bone deformed until it
was in contact with the lateral sides of the top supports. This
changed the distribution of the force at high deformations, and the
maximum strength was not applied in the same manner as in the
intact loading and other fractured-bone time points. Thus, the
maximum strength for day 7 PF of the fractured bones was not
included in this analysis. In the wild-type animals, the stiffness at
day 28 PF was significantly greater than at days 7 and 14, and the
maximum strength at day 28 PF was significantly greater than at
days 14 and 21. In Pten mutants, the stiffness at day 28 PF was
significantly greater than at days 7, 14, and 21, and the maximum
strength at day 28 PF was significantly greater than at day 14.
At all time points, the ratio of the biomechanical properties
(stiffness and maximum strength) of the fractured to intact limb
was not significantly different between the mutant and wild-type
groups (Figure 1c, f). At day 28 PF, the wild-type stiffness and
maximum strength were 57% (Figure 1c) and 79% (Figure 1f) of
the intact bone, respectively, and the mutant stiffness and force
returned to 74% (Figure 1c) and 78% (Figure 1f), respectively, of
the values of intact bone. By day 21 PF, the maximum strength for
the mutant exceeded that for the wild-type intact bone by 23%
(35.8 N for mutant, Figure 1e vs. 29.2 N for wild-type, Figure 1d),
and at day 28 PF that difference had increased to 34% (45.5 N for
mutant, Figure 1e vs. 33.9 N for wild-type, Figure 1d).
Table 1. Callus histomorphometric measures (*p,0.05 WT to Mut at the time point).
14 days PF 21 days PF
Measure Abbreviation WT Mut WT Mut
Bone surface (mm) BS 2768 3062 2861 2362*
Osteoblast surface (mm) Ob.S 8.764.6 9.961.2 5.762.6 5.962.8
Osteoclast surface (mm) Oc.S 1.660.1 2.360.3* 2.160.4 1.860.3
Erosion surface (mm) ES 1.960.2 2.960.1* 3.660.3 2.960.2*
Erosion surface with osteoclast (mm) ES(Oc+) 1.660.1 2.360.3* 2.160.4 1.860.3
Number of osteoblasts N.Ob 5616277 682674 4026189 4256198
Number of osteoclasts N.Oc 5364 6964* 63612 55612
Osteoblast surface per bone surface (%) Ob.S/BS 3167 3362 2069 25611
Osteoclast surface per bone surface (%) Oc.S/BS 6.261.5 7.760.8 7.361.6 7.760.9
Erosion surface per bone surface (%) ES/BS 7.862.8 9.561.1 12.861.6 12.960.8
Erosion surface with osteoclast per bone
surface (%)
ES(Oc+)/BS 6.261.5 7.660.8 7.061.5 7.560.8
Number of osteoblasts per bone perimeter
(#/mm)
N.Ob/B.Pm 2064 2262 1467 1868
Number of osteoclasts per bone perimeter
(#/mm)
N.Oc/B.Pm 2.160.4 2.360.2 2.260.4 2.460.3
doi:10.1371/journal.pone.0063857.t001
Pten Knockouts Have Improved Fracture Healing
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To gain further insight into how Pten deficiency in osteoblasts
affects fracture healing, we examined mCT scans (representative
longitudinal images are shown in Figure 2 and cross-sectional
images in Figure 3). Images were taken an average of 2.7 mm from
the fracture to compare the intramembranous ossification arising
from the periosteum. Pten mutants had increased ossification in
the region away from the fracture (a significant difference at day 7;
Figure 4a), where osteogenesis is likely due to intramembranous
ossification [4]. At day 21 PF, the intramembranous bone had
already grown so dense that it is difficult to distinguish where the
existing bone ends and the newly formed bone begins without
multiple cross sections (Figures 2 and 3).
We calculated BV/TV (Figure 4), callus mineral content,
volume, and density (Figure 5) from the mCT data. At day 7 PF,
the mutants had significantly higher BV/TV in the callus ends and
at day 28 PF the mutants had significantly higher BV/TV in the
central callus. At days 7, 14, and 21 PF, the mutants had
significantly more mineral content and volume than the wild-type
animals. The mutants had a denser callus at each time point, but
the difference was only significant on day 14 PF.
We performed western blotting to analyze the protein
expression in the fracture calluses throughout the healing process.
The expression of phosphorylated Akt (p-Akt) was increased in the
mutants at days 14, 21, and 28 days PF but the difference was not
significant (Figure 6; Figure S2).
We performed histological analysis on the fracture calluses. At
day 7 PF, each callus was composed of mainly fibroblast cells and
chondrocytes (Figure S3). By day 14 PF, woven bone had replaced
some of the chondrocytes and was apparent throughout the callus
(Figure 7). There were regions where the woven bone surrounds
hypertrophic chondrocytes, which demonstrated that the bone was
undergoing endochondral ossification. By day 21 PF, bone had
replaced most of the cartilage matrix (Figures S4 and S5).
We performed immunohistochemistry analysis on the fracture
calluses. The Pten IHC staining was similar between the wild-type
and mutant groups in the callus at day 7 PF but was more intense
in the mutant group in the bone lining cells at days 14, 21 and
28 PF (Figures S6, S7, S8, S9). The expression of phosphorylated
Akt (p-Akt) was observed in bone lining cells surrounding the
newly formed bone and was similar in the wild-type and mutant
groups at day 14 PF (Figure S10) and 21 PF (Figure S11). The
expression of phosphorylated ribosomal S6 kinase 1 (p-S6) was
observed in bone lining cells surrounding the newly formed bone
and was similar in the wild-type and mutant groups at day 14 PF
(Figure S12) and 21 PF (Figure S13). TRAP staining was increased
in the mutant group at days 14 and 21 (Figures 8 and S14).
Discussion
Relative to wild-type mice, mice lacking Pten in their osteoblasts
had significantly stiffer and stronger intact bones at all time points.
This result confirms the previous study in which the bones of the
Pten mutants had a higher bone mineral density and more
midshaft cortical bone in the femur [17], i.e. bone density and
material distribution contribute to biomechanical stiffness [29].
Biomechanical analysis also showed that Pten mutants had
significantly stiffer (day 28 PF) and stronger (days 14, 21 and
28 PF) healing bones at the later stages of the healing process. At
earlier stages of healing, the increase in newly formed bone at the
proximal and distal ends of the callus (Figure 4a) by itself
contributed little to the overall biomechanical stiffness and
strength of the callus: during biomechanical testing, the callus
broke at the weakest point, which was the more central
cartilaginous region near the original fracture. That the biome-
chanical difference between the two groups was not apparent until
later in the healing process (days 14, 21 and 28 PF) is expected
because the only cells in which Pten is absent express osteocalcin,
and those cells do not appear near the fracture site until day 10 or
14 PF. Reporter mice for osterix [20], collagen I alpha I [30], and
osteocalcin [30] activity have defined the location of cells from the
osteoblastic lineage during fracture repair. Osterix-positive oste-
oblast precursors entered the callus along with the invading blood
vessels [20]. Collagen I alpha I cells were apparent in the callus by
day 4 PF; at day 7 PF, osteocalcin-positive cells were present near
the bone originating from the periosteum at the proximal and
distal ends of the callus but not near the fracture site [30]. As early
as day 10 PF, osteocalcin-positive cells were evident in the callus,
although they were still less common than the collagen I alpha I-
positive cells; the more prevalent collagen I alpha I-positive cells
indicate the cells are earlier in the osteoblast differentiation process
[30]. At day 14 PF, mature osteoblasts were located near the outer
shell of the callus near the fracture site [30] where the addition of
bone is the most biomechanically advantageous [29], and
throughout the callus [31]. The improved stiffness and maximum
strength of fractured bones from the Pten mutants is consistent
with the increased BV/TV in the central callus at that time
(Figure 4b) and demonstrated improved fracture healing. By day
21 PF, the fracture callus of the Pten mutants was stronger than
the wild-type intact bone, which further demonstrated that the
inhibition of Pten enhanced fracture healing. Increased ossification
at the proximal and distal ends of the callus (Figure 4a) supports
the inference that the inhibition of Pten enhanced intramembra-
nous ossification. The ratio of the biomechanical properties in the
fractured limb to the intact limb was not significantly different
between the wild-type and mutants (Figure 1c, f). This indicates
that fracture healing of the bone occurs at the same rate as the
growth of the bone in each group, i.e. Pten mutants grow bone
better in development (Figure 1a, d) and fracture healing
(Figure 1b, e).
The qualitative appearance of the callus did not appear different
between the mutant and wild-type groups in the H&E stained
images (Figures 7 and S3, S4, S5). The wild-type and mutant
groups appeared to heal with similar kinetics in the same manner.
The progression of healing in the cartilaginous callus followed the
same pattern as that of bone built during normal endochondral
ossification. However, at a later time point in fracture healing
when mature osteoblasts that produce osteocalcin were present,
the Pten mutants had decreased Pten expression (Figures S6, S7,
S8, S9), and increased ossification, as shown by the increased
thickness of bone at the proximal and distal ends of the callus. This
also likely occurred near the fracture site later in the healing and is
consistent with the observation that the biomechanical strength
and stiffness of the Pten mutants were both improved only at day
28 PF relative to the wild-type intact femur. The Pten mutants also
had increased TRAP staining at days 14 and 21 PF (Figures 8 and
S14). The mutants also had significantly more osteoclasts,
osteoclast surface, and eroded surface in the fracture callus
(Table 1) at day 14 PF, which is consistent with our character-
ization of the mice [17], though these differences were not
significant when normalized to bone surface (Table 1). This
demonstrates that the mutant bones are not stronger because of
decreased osteoclast activity. It is expected that at later time points
than those studied here, the difference in the strength and stiffness
between the mutants and wild-type would be more pronounced,
because the Pten-deficient osteoblasts will continue to provide
more mineralization than the wild-type osteoblasts. Protein
extracts showed decreased Pten and increased Akt signaling (p-
Akt) in the mutants at day 21 PF. The expression of Pten in the
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mutants could be from cells other than osteoblasts in the fracture
callus (e.g., chondrocytes and fibroblasts).
This study used a computational measure of the three-
dimensional callus characteristics to assess fracture healing. Previous
studies have used select slices in CT scan analysis [26,32]. Our
method demonstrated an increased callus mineral content and
volume in the Pten mutant mice relative to the wild-type. The
improved callus mineral content and mineralized callus volume
indicated that mice lacking Pten in osteoblasts healed more robustly
than the wild-type mice. The observed increase in callus size and
callus mineral content is expected to increase callus strength. These
results indicate that inhibition of Pten could improve fracture
healing and could be a candidate treatment for non-union.
Future work should address whether Pten can be inhibited
locally and can improve the growth of bone after fracture. Despite
the fact that Pten is a known tumor suppressor [15], transient
inhibition of Pten is being evaluated to treat other conditions. For
example, there has already been work in developing agents that
inhibit the activity of Pten to treat diabetes [33], provide cardiac
protection against ischemia/reperfusion injury [34], reduce the
severity of acute lung injury [35], and accelerate wound closure
[36]. Some of these agents are commercially available, and it is
crucial to note that such agents have already been used in mouse
models with no evidence of deleterious effects. Given that that the
half-life of Pten protein is 48–72 hours [37] and the half-life of this
inhibitor is also relatively short [35], a strategy of transient
inhibition should be practical. Such a strategy would further
reduce the chances of any negative effects. The results of this study
indicate that the inhibition of Pten can improve fracture healing,
and that the local or short-term transient use of these Pten-
inhibiting agents has potential clinical applications to enhance
fracture healing.
Supporting Information
Figure S1 Schematics of mCT scanning and mechanical
testing setup. (A) Representative screenshots of callus cropped
fractured bone (darker gray) and intact bone (lighter gray) masks
from one mouse 14 d PF. (B) Schematic demonstrating how the
callus volume and mineral content was calculated from Mimics.
Fractured bone and callus (darker gray) minus the bone (lighter
gray) equals the callus (darkest gray). The horizontal lines indicate
where the masks were cropped. (C) Mechanical testing setup for
fractured bone and callus (darker gray) and intact bone (lighter
gray).
(TIF)
Figure S2 Quantitation of western blots. (A) Mutant
animals trended to have more normalized p-Akt than wildtype
animals. (B) Mutant animals trended to have less normalized Pten
than wildtype animals.
(TIF)
Figure S3 H&E of fracture calluses at day 7 PF. (A) 46
magnification of wild-type callus; (B) 106magnification of the box
from (A); (C) 46magnification of Pten mutant callus; and (D) 106
magnification of the box from (C). The fracture callus consisted of
mostly fibroblast cells and chondrocytes in each case.
(TIF)
Figure S4 H&E of fracture calluses at day 21 PF. (A) 46
magnification of wild-type callus; (B) 106 magnification of box
from (A); (C) 46magnification of Pten mutant callus; and (D) 106
magnification of box from (C). Woven bone had replaced the
cartilage matrix in each case.
(TIF)
Figure S5 H&E of fracture calluses at day 28 PF. (A) 46
magnification of wild-type callus; (B) 106 magnification of box
from (A); (C) 46magnification of Pten mutant callus; and (D) 106
magnification of box from (C). The callus consists of mostly woven
bone in each case.
(TIF)
Figure S6 Pten IHC of fracture calluses at day 7 PF. (A)
106 magnification of wild-type callus; (B) 206 magnification of
box from (A); (C) 106 magnification of Pten mutant callus; (D)
206magnification of box from (C). Pten was expressed at a similar
level in each case.
(TIF)
Figure S7 Pten IHC of fracture calluses at day 14 PF. (A)
106 magnification of wild-type callus; (B) 206 magnification of
box from (A); (C) 106 magnification of Pten mutant callus; (D)
206magnification of box from (C). Pten was expressed at a higher
level in the bone lining cells in the wildtype animals.
(TIF)
Figure S8 Pten IHC of fracture calluses at day 21 PF. (A)
106 magnification of wild-type callus; (B) 206 magnification of
box from (A); (C) 106 magnification of Pten mutant callus; (D)
206magnification of box from (C). Pten was expressed at a higher
level in the bone lining cells in the wildtype animals.
(TIF)
Figure S9 Pten IHC of fracture calluses at day 28 PF. (A)
106 magnification of wild-type callus; (B) 206 magnification of
box from (A); (C) 106 magnification of Pten mutant callus; (D)
206magnification of box from (C). Pten was expressed at a higher
level in the bone lining cells in the wildtype animals.
(TIF)
Figure S10 p-Akt IHC of fracture calluses at day 14 PF.
(A) 106magnification of wild-type callus; (B) 206magnification of
box from (A); (C) 106 magnification of Pten mutant callus; (D)
206 magnification of box from (C). p-Akt was expressed at a
similar level in each case.
(TIF)
Figure S11 p-Akt IHC of fracture calluses at day 21 PF.
(A) 106magnification of wild-type callus; (B) 206magnification of
box from (A); (C) 106 magnification of Pten mutant callus; (D)
206 magnification of box from (C). p-Akt was expressed at a
similar level in each case.
(TIF)
Figure S12 p-S6 IHC of fracture calluses at day 14 PF(A)
106 magnification of wild-type callus; (B) 206 magnifi-
cation of box from (A); (C) 106 magnification of Pten
mutant callus; (D) 206magnification of box from (C). p-
S6 was expressed at a similar level in each case.
(TIF)
Figure S13 p-S6 IHC of fracture calluses at day 21 PF.
(A) 106magnification of wild-type callus; (B) 206magnification of
box from (A); (C) 106 magnification of Pten mutant callus; (D)
206magnification of box from (C). p-S6 was expressed at a similar
level in each case.
(TIF)
Figure S14 TRAP stain of fracture calluses at day 21 PF.
(A) 106magnification of wild-type callus; (B) 206magnification of
box from (A); (C) 106 magnification of Pten mutant callus; (D)
206 magnification of box from (C). TRAP staining was more
intense in the mutant group.
(TIF)
Pten Knockouts Have Improved Fracture Healing
PLOS ONE | www.plosone.org 8 May 2013 | Volume 8 | Issue 5 | e63857
Document S1 Supplemental methods.
(DOCX)
Acknowledgments
The authors thank the members of the Mason and Williams labs
at VARI for their assistance; David Nadziejka for assistance
preparing the manuscript; DJ Scholten for assisting on surgeries
and fractures; Lisa Turner and the VARI histology core for their
histology work; Michael Starbuck in the Rolanette and Berdon
Lawrence Bone Disease Program of Texas bone histomorphom-
etry lab for his help with the histomorphometry analysis; VARI’s
vivarium staff for outstanding animal husbandry; and Luci Korpi
and the Grand Rapids Area Pre-College Engineering Program for
helping with this research.
Author Contributions
Conceived and designed the experiments: TAB DLS JJM CBJ BOW.
Performed the experiments: TAB JZ MFH MRM MAA. Analyzed the
data: TAB MFH CJC JJM HLP BOW. Contributed reagents/materials/
analysis tools: JJM BOW. Wrote the paper: TAB MFH JJM BOW.
References
1. Phillips AM (2005) Overview of the fracture healing cascade. Injury 36 Suppl 3:
S5–7.
2. Ferguson CM, Miclau T, Hu D, Alpern E, Helms JA (1998) Common molecular
pathways in skeletal morphogenesis and repair. Ann N Y Acad Sci 857: 33–42.
3. Einhorn TA (1998) The cell and molecular biology of fracture healing. Clin
Orthop Relat Res: S7–21.
4. Gerstenfeld LC, Cullinane DM, Barnes GL, Graves DT, Einhorn TA (2003)
Fracture healing as a post-natal developmental process: molecular, spatial, and
temporal aspects of its regulation. J Cell Biochem 88: 873–884.
5. Parker MJ, Raghavan R, Gurusamy K (2007) Incidence of fracture-healing
complications after femoral neck fractures. Clin Orthop Relat Res 458: 175–
179.
6. Court-Brown CM, McQueen MM (2008) Nonunions of the proximal humerus:
their prevalence and functional outcome. J Trauma 64: 1517–1521.
7. Coulibaly MO, Sietsema DL, Burgers TA, Mason J, Williams BO, et al. (2010)
Recent advances in the use of serological bone formation markers to monitor
callus development and fracture healing. Crit Rev Eukaryot Gene Expr 20: 105–
127.
8. Valdes MA, Thakur NA, Namdari S, Ciombor DM, Palumbo M (2009)
Recombinant bone morphogenic protein-2 in orthopaedic surgery: a review.
Arch Orthop Trauma Surg 129: 1651–1657.
9. Nakae J, Kido Y, Accili D (2001) Distinct and overlapping functions of insulin
and IGF-I receptors. Endocr Rev 22: 818–835.
10. Kawamura N, Kugimiya F, Oshima Y, Ohba S, Ikeda T, et al. (2007) Akt1 in
osteoblasts and osteoclasts controls bone remodeling. PLoS One 2: e1058.
11. Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science 296: 1655–
1657.
12. Hers I, Vincent EE, Tavare JM (2011) Akt signalling in health and disease. Cell
Signal 23: 1515–1527.
13. Mayo LD, Donner DB (2002) The PTEN, Mdm2, p53 tumor suppressor-
oncoprotein network. Trends Biochem Sci 27: 462–467.
14. Yuan TL, Cantley LC (2008) PI3K pathway alterations in cancer: variations on
a theme. Oncogene 27: 5497–5510.
15. Simpson L, Parsons R (2001) PTEN: life as a tumor suppressor. Exp Cell Res
264: 29–41.
16. Paez J, Sellers WR (2003) PI3K/PTEN/AKT pathway. A critical mediator of
oncogenic signaling. Cancer Treat Res 115: 145–167.
17. Liu X, Bruxvoort KJ, Zylstra CR, Liu J, Cichowski R, et al. (2007) Lifelong
accumulation of bone in mice lacking Pten in osteoblasts. Proc Natl Acad
Sci U S A 104: 2259–2264.
18. Bonnarens F, Einhorn TA (1984) Production of a standard closed fracture in
laboratory animal bone. J Orthop Res 2: 97–101.
19. Phieffer LS, Goulet JA (2006) Delayed unions of the tibia. J Bone Joint Surg Am
88: 206–216.
20. Maes C, Kobayashi T, Selig MK, Torrekens S, Roth SI, et al. (2010) Osteoblast
precursors, but not mature osteoblasts, move into developing and fractured
bones along with invading blood vessels. Dev Cell 19: 329–344.
21. Hugunin KM, Fry C, Shuster K, Nemzek JA (2010) Effects of tramadol and
buprenorphine on select immunologic factors in a cecal ligation and puncture
model. Shock 34: 250–260.
22. Harrysson O, Hosni Y, Nayfeh J (2007) Custom-designed orthopedic implants
evaluated using finite element analysis of patient-specific computed tomography
data: femoral-component case study. BMC Musculoskelet Disord 8: 91.
23. Burgers TA, Mason J, Ploeg HL (2009) Initial fixation of a femoral knee
component: an in vitro and finite element study. International Journal of
Experimental and Computational Biomechanics 1: 23–44.
24. Rho JY, Hobatho MC, Ashman RB (1995) Relations of mechanical properties to
density and CT numbers in human bone. Med Eng Phys 17: 347–355.
25. Burgers TA, Mason J, Niebur G, Ploeg HL (2008) Compressive properties of
trabecular bone in the distal femur. J Biomech 41: 1077–1085.
26. Komatsu DE, Mary MN, Schroeder RJ, Robling AG, Turner CH, et al. (2010)
Modulation of Wnt signaling influences fracture repair. J Orthop Res 28: 928–
936.
27. Doube M, Klosowski MM, Arganda-Carreras I, Cordelieres FP, Dougherty RP,
et al. (2010) BoneJ: Free and extensible bone image analysis in ImageJ. Bone 47:
1076–1079.
28. Conrads KA, Yi M, Simpson KA, Lucas DA, Camalier CE, et al. (2005) A
combined proteome and microarray investigation of inorganic phosphate-
induced pre-osteoblast cells. Mol Cell Proteomics 4: 1284–1296.
29. Aiyangar AK, Au AG, Crenshaw TD, Ploeg HL (2010) Recovery of bone
strength in young pigs from an induced short-term dietary calcium deficit
followed by a calcium replete diet. Med Eng Phys 32: 1116–1123.
30. Ushiku C, Adams DJ, Jiang X, Wang L, Rowe DW (2010) Long bone fracture
repair in mice harboring GFP reporters for cells within the osteoblastic lineage.
J Orthop Res 28: 1338–1347.
31. Thompson Z, Miclau T, Hu D, Helms JA (2002) A model for intramembranous
ossification during fracture healing. J Orthop Res 20: 1091–1098.
32. Gaur T, Wixted JJ, Hussain S, O’Connell SL, Morgan EF, et al. (2009) Secreted
frizzled related protein 1 is a target to improve fracture healing. J Cell Physiol
220: 174–181.
33. Rosivatz E (2007) Inhibiting PTEN. Biochem Soc Trans 35: 257–259.
34. Cai ZP, Shen Z, Van Kaer L, Becker LC (2008) Ischemic preconditioning-
induced cardioprotection is lost in mice with immunoproteasome subunit low
molecular mass polypeptide-2 deficiency. Faseb J 22: 4248–4257.
35. Lai JP, Bao S, Davis IC, Knoell DL (2009) Inhibition of the phosphatase PTEN
protects mice against oleic acid-induced acute lung injury. Br J Pharmacol 156:
189–200.
36. Takeda S, Mochizuki S, Saini HK, Elimban V, Dhalla NS (2005) Modification
of alterations in cardiac function and sarcoplasmic reticulum by vanadate in
ischemic-reperfused rat hearts. J Appl Physiol 99: 999–1005.
37. Wu X, Hepner K, Castelino-Prabhu S, Do D, Kaye MB, et al. (2000) Evidence
for regulation of the PTEN tumor suppressor by a membrane-localized multi-
PDZ domain containing scaffold protein MAGI-2. Proc Natl Acad Sci U S A 97:
4233–4238.
Pten Knockouts Have Improved Fracture Healing
PLOS ONE | www.plosone.org 9 May 2013 | Volume 8 | Issue 5 | e63857
